To further determine if LSD1/SIRT1 competitive interaction with KU70 may indeed affect BCR-ABL mutation acquisition, we over-expressed WT or ΔSAP KU70 into CML cells. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.